ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $40,394 | -20.4% | 18,788 | -27.8% | 0.00% | – |
| Q1 2023 | $50,755 | -5.3% | 26,028 | +86.4% | 0.00% | – |
| Q4 2022 | $53,618 | -76.5% | 13,963 | -70.6% | 0.00% | – |
| Q3 2022 | $228,000 | +34.9% | 47,422 | +312.4% | 0.00% | – |
| Q1 2022 | $169,000 | -97.3% | 11,500 | -96.3% | 0.00% | – |
| Q4 2021 | $6,210,000 | +164.4% | 307,532 | +255.5% | 0.00% | – |
| Q3 2021 | $2,349,000 | -2.9% | 86,500 | -12.9% | 0.00% | – |
| Q2 2021 | $2,418,000 | -46.2% | 99,324 | -46.0% | 0.00% | – |
| Q1 2021 | $4,494,000 | +153.6% | 184,088 | +232.4% | 0.00% | – |
| Q4 2020 | $1,772,000 | +427.4% | 55,388 | +443.0% | 0.00% | – |
| Q3 2020 | $336,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |